Earnings from Biogen Inc. [BIIB] are scheduled on April 22, 2021, before the market opens. It is expected that the company will report weak earnings for the quarter ending Mar 2021.
BIIB Stock Earnings Outlook For The Current Quarter
The consensus estimates for the quarter suggest that the company would earn $5.04 per share on revenue of $2.65B. Taking a look at the future, the company is projected to report revenue of $2.62B at an earnings per share of $4.77 for the Jun 2021 quarter. The estimates represent year-over-year improvements of 0.50% in revenue and 8.79% in earnings per share for the company.
BIIB Stock Earnings Forecast For The Current Year
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
For the full financial year, Biogen Inc. [NASDAQ:BIIB] is forecasted to generate revenue of $10.57B. The figure is about $-2.87 billion below what the company actually reported for the fiscal year 2020. In terms of EPS, it is estimated to be $18.41 in 2021, which is -$15.29 lower than the figure in FY20. Based on current estimates, earnings are expected to grow -45.40% this year, 8.80% next year, and -10.23% annually over the next five years. With regard to sales, forecasts suggest a decline of -21.40% in current fiscal year and 0.50% over following year.
BIIB Stock Price Performance
At the close of Wednesday’s session, Biogen Inc. [NASDAQ:BIIB] finished down -1.23% at $269.85. The stock’s highest single-day price was $273.385, and its lowest was $266.50. Its price rose 1.53% in the last five days. Since the beginning of the year, Biogen Inc.’s shares are up nearly 10.21%. However, the share price is -25.85% below its one year high. The top price reached by the shares of the company was $296.38 on 01/29/21, while the 52-week low came on 01/04/21, when the shares were $238.40. In the past year, shares of the company have fallen -20.49%. At 50 days, the moving average achieved is $271.27 while at 200 days, the moving average is $269.01. There were 1.03 million shares traded in the last session, up from 0.84 million in the previous session.
Biogen Inc. [NASDAQ:BIIB] Stock Valuation Metrics
With a prevailing 12-month PE ratio of 11.04, Biogen Inc. [BIIB] does qualify as a good candidate for the list of underestimated low-priced stocks that should be purchased sooner rather than later. By this measure, the company’s stock is trading at a discount to the industry average of 24.06 times trailing earnings. Investors may find it helpful to look at historical price-sales ratios, and in the case of this stock, 3.06 PS value ratio is reported for the last one year of reported earnings. This is below the average return 3.14 for the industry, which means BIIB offers an attractive investment opportunity than its competitors do.
BIIB Share Price Support And Resistance Levels
Based on the daily chart, the immediate backing lies around the 269.85 level, and the violation of this level will cause a further drop to 266.44 level. At the upper end, 280.21 remains a key resistance. As the stock increases, it may find resistance at 276.80. In the 14-day chart, the Relative Strength Index standing at 49.86 suggests a technical neutral stance while the MACD standing at 0.85 indicates price will decrease in the next trading period. Stochastic %K at 42.55% suggests holding the stock while Percent R indicator at 61.82% suggests low price movement.
How much is the short interest in Biogen Inc.?
There have been a drop in short interest in the Biogen Inc. Financial stock, with short interest up by 80000.0 shares to 3.57 million shares on Feb 25, 2021. According to data provided by Yahoo Finance, the short interest on Mar 30, 2021 stood at 3.65 million shares. This -2.24% decrease suggests some bullish sentiment was experienced by the stock. Shorted shares accounted for just 2.41% of the overall float in the stock, while the stock’s days to cover moved to 2.84.
How do analysts view Biogen Inc.?
In regard to the share price forecast for Biogen Inc. stock, the analysts, as surveyed by FactSet, forecast the price to reach $269.00 in the next twelve months, representing almost an -0.32% growth from its recent price of $269.85. Among Biogen Inc. stock projections, $458.00 is the highest analyst target for the stock, while $166.00 is the lowest. Despite this, 33 analysts who share their consensus rating for BIIB in 2021 agree that the stock is a Hold. The latest rating change took place on 4/19/21, when Morgan Stanley Ratings launched coverage of the stock at “Overweight” and assigned a price target of $343.0.